{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:06:49Z","timestamp":1791194809447,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000985","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:09:55Z","timestamp":1300302595000},"page":"e985","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse"],"prefix":"10.1371","volume":"5","author":[{"given":"Paul J.","family":"Converse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak V.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Nuermberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques H.","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.","volume":"271","author":"GA Colditz","year":"1994","journal-title":"Jama"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0140-6736(92)90794-4","article-title":"Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.","volume":"339","author":"JM Ponnighaus","year":"1992","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2006.75.768","article-title":"BCG vaccine effectiveness against Buruli Ulcer: a case-control study in Benin.","volume":"75","author":"F Nackers","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.72.1.62-65.2004","article-title":"<italic>Mycobacterium bovis<\/italic> BCG vaccination as prophylaxis against <italic>Mycobacterium ulcerans<\/italic> osteomyelitis in Buruli ulcer disease.","volume":"72","author":"F Portaels","year":"2004","journal-title":"Infect Immun"},{"key":"ref5","first-page":"1389","article-title":"Prophylactic effect of <italic>Mycobacterium bovis<\/italic> BCG vaccination against osteomyelitis in children with <italic>Mycobacterium ulcerans<\/italic> disease (Buruli Ulcer).","volume":"9","author":"F Portaels","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against <italic>Mycobacterium ulcerans<\/italic> disease: a controlled trial in an endemic area of Uganda.","volume":"70","author":"PG Smith","year":"1976","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref7","first-page":"111","article-title":"BCG vaccination against <italic>Mycobacterium ulcerans<\/italic> infection (Buruli ulcer). First results of a trial in Uganda.","volume":"1","year":"1969","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1128\/IAI.70.10.5562-5567.2002","article-title":"Cytokine profiles of patients infected with <italic>Mycobacterium ulcerans<\/italic> and unaffected household contacts.","volume":"70","author":"TM Gooding","year":"2002","journal-title":"Infect Immun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/IAI.69.3.1704-1707.2001","article-title":"Immune Response to Infection with <italic>Mycobacterium ulcerans<\/italic>.","volume":"69","author":"TM Gooding","year":"2001","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.micinf.2006.03.009","article-title":"Immunogenicity of <italic>Mycobacterium ulcerans<\/italic> Hsp65 and protective efficacy of a <italic>Mycobacterium leprae<\/italic> Hsp65-based DNA vaccine against Buruli ulcer.","volume":"8","author":"E Coutanceau","year":"2006","journal-title":"Microbes and Infection"},{"key":"ref11","first-page":"IAI.01622","article-title":"A booster vaccination with <italic>M. bovis<\/italic> BCG does not increase the protective effect of the vaccine against experimental <italic>Mycobacterium ulcerans<\/italic> infection in mice.","author":"A Tanghe","year":"2007"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from <italic>Mycobacterium bovis<\/italic> BCG against Buruli Ulcer.","volume":"69","author":"A Tanghe","year":"2001","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/path.1700600111","article-title":"A new mycobacterial infection in man.","volume":"60","author":"P MacCallum","year":"1948","journal-title":"J Pathol Bacteriol"},{"key":"ref14","first-page":"293","article-title":"Necrotic tropical ulcers and mycobacterial causative agents.","volume":"11","author":"PG Janssens","year":"1959","journal-title":"Trop Geogr Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(61)90793-0","article-title":"Mycobacterial skin ulcers in Uganda.","volume":"2","author":"JK Clancey","year":"1961","journal-title":"Lancet"},{"key":"ref16","article-title":"Epidemiology.","author":"K Asiedu","year":"2000"},{"key":"ref17","article-title":"WHO joins battle against a new emerging disease, Buruli ulcer. Geneva: World Health Organization.","volume":"88","year":"1997","journal-title":"Press Release WHO\/88 Press Release WHO\/"},{"key":"ref18","first-page":"163","article-title":"Buruli ulcer disease.","volume":"78","year":"2003","journal-title":"Weekly Epidemiological Record"},{"key":"ref19","article-title":"<italic>Mycobacterium ulcerans<\/italic> infection (with comments on pathogenesis).","volume":"33","author":"DH Connor","year":"1965","journal-title":"Int J Lepr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from <italic>Mycobacterium ulcerans<\/italic> required for virulence.","volume":"283","author":"KM George","year":"1999","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1128\/IAI.9.6.1114-1122.1974","article-title":"Cytotoxic activity of <italic>Mycobacterium ulcerans<\/italic>.","volume":"9","author":"JK Read","year":"1974","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/JB.187.5.1668-1676.2005","article-title":"Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of <italic>Mycobacterium ulcerans<\/italic>.","volume":"187","author":"TP Stinear","year":"2005","journal-title":"J Bacteriol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1073\/pnas.0305877101","article-title":"Giant plasmid-encoded polyketide synthases produce the macrolide toxin of <italic>Mycobacterium ulcerans<\/italic>.","volume":"101","author":"TP Stinear","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1099\/mic.0.27674-0","article-title":"Functional analysis and annotation of the virulence plasmid pMUM001 from <italic>Mycobacterium ulcerans<\/italic>.","volume":"151","author":"TP Stinear","year":"2005","journal-title":"Microbiology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1128\/IAI.73.10.6299-6310.2005","article-title":"Infection with <italic>Mycobacterium ulcerans<\/italic> Induces Persistent Inflammatory Responses in Mice.","volume":"73","author":"MS Oliveira","year":"2005","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.00889-06","article-title":"Evidence for an intramacrophage growth phase of <italic>Mycobacterium ulcerans<\/italic>.","volume":"75","author":"E Torrado","year":"2007","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4269\/ajtmh.2005.73.410","article-title":"High rates of apoptosis in human <italic>Mycobacterium ulcerans<\/italic> culture-positive Buruli ulcer skin lesions.","volume":"73","author":"DS Walsh","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1462-5822.2005.00557.x","article-title":"<italic>Mycobacterium ulcerans<\/italic> toxic macrolide, mycolactone modulates the host immune response and cellular location of <italic>M. ulcerans<\/italic> in vitro and in vivo.","volume":"7","author":"S Adusumilli","year":"2005","journal-title":"Cellular Microbiology"},{"key":"ref29","first-page":"650","article-title":"The pathogenic behavior of <italic>Mycobacterium ulcerans<\/italic> and <italic>Mycobacterium balnei<\/italic> in the mouse and the developing chick embryo.","volume":"73","author":"F Fenner","year":"1956","journal-title":"Am Rev Tuberc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.1974.01630110073023","article-title":"Toxin of <italic>Mycobacterium ulcerans<\/italic>. Production and effects in guinea pig skin.","volume":"110","author":"RE Krieg","year":"1974","journal-title":"Arch Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/AAC.45.11.3109-3112.2001","article-title":"Activities of new macrolides and fluoroquinolones against <italic>Mycobacterium ulcerans<\/italic> infection in mice.","volume":"45","author":"A Bentoucha","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/AAC.44.9.2367-2372.2000","article-title":"Activities of several antimicrobials against <italic>Mycobacterium ulcerans<\/italic> infection in mice.","volume":"44","author":"H Dega","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","first-page":"187","article-title":"<italic>Mycobacterium ulcerans<\/italic> infection. Clinical and bacteriological study of the first cases recognized in South East Asia.","volume":"78","author":"JHS Pettit","year":"1966","journal-title":"British Journal of Dermatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/AAC.01260-10","article-title":"Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with <italic>Mycobacterium ulcerans<\/italic> Infection.","volume":"55","author":"T Zhang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/AAC.46.10.3193-3196.2002","article-title":"Bactericidal activity of rifampin-amikacin against <italic>Mycobacterium ulcerans<\/italic> in mice.","volume":"46","author":"H Dega","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","first-page":"429","article-title":"A kinetic method for the study of the activity of drugs against <italic>Mycobacterium leprae<\/italic>.","volume":"35","author":"CC Shepard","year":"1967","journal-title":"Int J Lepr"},{"key":"ref37","first-page":"458","article-title":"Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.","volume":"76","author":"HF Lecoeur","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice.","volume":"182","author":"S Lopez Kostka","year":"2009","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2009.03941.x","article-title":"Differences in virulence and immune response induced in a murine model by isolates of <italic>Mycobacterium ulcerans<\/italic> from different geographic areas.","volume":"157","author":"RH Ortiz","year":"2009","journal-title":"Clinical & Experimental Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)00605-6","article-title":"Emergence of the Th17 pathway and its role in host defense.","volume":"99","author":"DB O'Quinn","year":"2008","journal-title":"Adv Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.","volume":"184","author":"Y Okamoto Yoshida","year":"2010","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2567.1998.00419.x","article-title":"Resistance ranking of some common inbred mouse strains to <italic>Mycobacterium tuberculosis<\/italic> and relationship to major histocompatibility complex haplotype and Nramp1 genotype.","volume":"93","author":"E Medina","year":"1998","journal-title":"Immunology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2567.1999.00663.x","article-title":"Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination.","volume":"96","author":"E Medina","year":"1999","journal-title":"Immunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1099\/00221287-148-10-2959","article-title":"Reduced up-regulation of memory and adhesion\/integrin molecules in susceptible mice and poor expression of immunity to pulmonary tuberculosis.","volume":"148","author":"V Gruppo","year":"2002","journal-title":"Microbiology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1128\/IAI.02048-05","article-title":"Role for matrix metalloproteinase 9 in granuloma formation during pulmonary <italic>Mycobacterium tuberculosis<\/italic> infection.","volume":"74","author":"JL Taylor","year":"2006","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0962-8479(97)90016-2","article-title":"Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent <italic>Mycobacterium tuberculosis<\/italic>.","volume":"78","author":"ER Rhoades","year":"1997","journal-title":"Tubercle and Lung Disease"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:55:02Z","timestamp":1592391302000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000985"}},"subtitle":[],"editor":[{"given":"Craig R.","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000985","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}